Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Bioethics, Ltd. (BOTH)
Ogden, UT, US
Established in 1990 and located in Ogden, Utah, Bioethics, Ltd. is not currently involved in substantial business activities. Instead, the company plans to explore, assess, and, if appropriate, acquire a stake in a new commercial enterprise.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -99.59% | -99.58% | -99.75% | -99.92% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Shell Companies: +20.6%—
-
EPS growth Shell Companies: -12.3%-40.2% Q4'24: +32.6% (vs Q4'23)
-
FCF margin FCF growth · Shell Companies: +8.7%—
-
EBIT margin Shell Companies: +0.0%—
-
ROIC Shell Companies: +0.0%— Q4'24: +37.0% (vs Q4'23)
-
Share dilution Shell Companies: -10.2%+31.5% Q4'24: +193.8% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Shell Companies: 0.00×-4.77× Q4'24: -1.19× (vs Q4'23)
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Douglas Morris | Vice President of Corporate Development & Director | — | male |
| Mark A. Scharmann | President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer & Director | — | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BOTH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
